Beijing Tsingke Biotech Co., Ltd., a prominent player in the DNA/RNA synthesis domain based in China, has entered into a strategic partnership with the Innovation Center of Yangtze River Delta, Zhejiang University. This high-capacity innovation platform is a joint initiative by Zhejiang University and Jiashan county in Jiaxing city of Zhejiang province. The collaboration aims to combine the strengths of both entities to establish a joint laboratory focused on the development of nucleic acid drug delivery systems. Details of the financial aspects of this partnership have not been disclosed.- Flcube.com
Recent news:
-
Sino Biopharmaceutical Submits NDA for Anlotinib and Penpulimab Combo in HCC to NMPA -
Sihuan Pharmaceutical's Huisheng Pharm Strikes Exclusive Deal for Semaglutide Biosimilar in China -
Innovent Biologics' IBI354 Earns Breakthrough Therapy Designation for Ovarian Cancer Treatment -
CDE Includes Double-Crane's Hydroxocobalamine and Sanofi Genzyme's Fitusiran in Rare Disease Care Plan -
Apeiron Therapeutics Initiates Phase Ia/B Study for GTA182 in Solid Tumors with MTAP Deficiency
